RxDoctor Payments DataLook up a doctor →

Bradley Andrew

Physician Assistant · American Fork, UTNPI 1801013230

Payments from drug & device makers

$11,574in general payments, 2019–2025

Across 689 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$802
  • Biogen$604
  • Pfizer$570
  • UCB, Inc.$534
  • MDD US Operations, LLC$486
  • plus $6K from 44 others

What the payments were for

  • Speaking & faculty fees$280%
  • Food & beverage$11,38098%
  • Education$1671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,574 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$35,783
Medicare patients
101
Services billed
3,253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Teriflunomide15$82,228
Nurtec OdtRimegepant Sulfate28$33,436
Aimovig AutoinjectorErenumab-Aooe28$20,882
QuliptaAtogepant14$19,753
AptiomEslicarbazepine Acetate12$15,445
OngentysOpicapone13$14,081
XcopriCenobamate12$13,645
Ajovy AutoinjectorFremanezumab-Vfrm17$12,222
Carbamazepine ErCarbamazepine47$5,793
Carbidopa-Levodopa ErCarbidopa/Levodopa85$4,818
Lacosamide46$4,472
Levetiracetam113$4,217
Carbidopa-LevodopaCarbidopa/Levodopa101$3,792
Lamotrigine125$3,204
Primidone67$3,161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt, Dilantin$570$36,55954 claims
AbbVieQulipta$2,565$19,75314 claims
Sunovion Pharmaceuticals Inc.Aptiom$50$15,44512 claims
Neurocrine Biosciences, Inc.Ongentys$472$14,08113 claims
SK Life Science, Inc.Xcopri$345$13,64512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in American Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →